We invest in great companies at a time when they are still very small


01 December 2014
Ascendis Pharma A/S Completes $60 million Oversubscribed Series D Financing

16 September 2014
Ascendis Pharma A/S Announces Positive Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency

26 August 2014
Cenix BioScience and Metanomics Health sign research agreement

05 May 2014
Cenix BioScience signs research service agreement with Bayer Pharma AG

Homepage Erstellung und Pflege: Superweb Homepage-Erstellung Version 1.0